Treatment with opioid antagonists and mtor inhibitors

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/436 (2006.01) A61K 31/165 (2006.01) A61K 31/451 (2006.01) A61K 31/485 (2006.01) A61P 3/10 (2006.01) A61P 7/00 (2006.01) A61P 7/06 (2006.01) A61P 19/02 (2006.01) A61P 27/00 (2006.01) A61P 35/00 (2006.01) A61P 37/02 (2006.01)

Patent

CA 2719134

Embodiments of the invention provide methods of treating a disorder or disease characterized by cellular proliferation and migration by co-administering a synergistically effective amount of an mTOR inhibitor and a µ-opioid receptor antagonist.

Des modes de réalisation de l'invention concernent des procédés pour traiter un trouble ou une maladie caractérisé par une prolifération et migration cellulaire par co-administration d'une quantité synergiquement efficace d'un inhibiteur Mtor et d'un antagoniste des récepteurs de µ-opioïdes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment with opioid antagonists and mtor inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment with opioid antagonists and mtor inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment with opioid antagonists and mtor inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1446583

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.